Webcast CME

Series Activities

Series Menu


Visit Virtual Exhibit Hall

Medical Dermatology Therapy Update



Update in Medical Treatment of Cutaneous Malignancies

Print this Content

Release Date:   January 26, 2021
Expiration Date:   January 26, 2023

Estimated Time of Completion:  1 hour and 15 minutes

Description

Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic diseases.

The Update in Medical Treatment of Cutaneous Malignancies webcast webcast will review the following medical conditions: melanoma and MF and Sezary Syndrome.

Learning Objectives

  1. Correlate clinical presentations of cutaneous T-cell lymphoma (CTCL) with T cell subtypes.
  2. Describe an appropriate treatment plan that is appropriate for Stage of disease.
  3. Use and interpret diagnostic tests for diagnosing and subtyping CTCL’s.
  4. Review changes in incidence and overall survival for melanoma with new systemic therapies of the last decade.
  5. Describe 2 major classes of systemic therapy for melanoma and mechanisms of action for each class.
  6. Discuss cutaneous toxicities as related to new systemic therapies in melanoma.
  7. Introduce upcoming developments in the systemic treatment of melanoma.

Target Audience

These activities are directed to physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Activity Director and Faculty

Activity Director

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Kevin Cooper, MD
Professor, Dermatology and Pathology
Case Western Reserve University School of Medicine
Interim Division Chief, Dermatology
University Hospitals Rainbow Babies and Children’s Hospital
Chairman, Department of Dermatology
University Hospitals Cleveland Medical Center
Cleveland, OH

Pauline Funchain, MD
Department of Hematology and Medical Oncology
Cleveland Clinic Cancer Center
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:


Kevin Cooper, MD
  Soligenix Research / Independent Contractor
Anthony P. Fernandez, MD, PhD
  AbbVie Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
  Celgene Corporation Consulting
  Corbus Pharmaceuticals Research / Independent Contractor
  Mallinckrodt Inc. Consulting
Research / Independent Contractor
Teaching and Speaking
  Novartis Consulting
Research / Independent Contractor
Teaching and Speaking
  Pfizer, Inc. Research / Independent Contractor
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
  UCB Consulting
Pauline Funchain, MD
  BMS, Pfizer Research / Independent Contractor

Acknowledgment

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation


This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Dermatology and Plastic Surgery Institute.